[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-001", "question": "A 68-year-old man with metastatic castration-resistant prostate cancer (mCRPC) on enzalutamide presents with progressive dyspnea and fatigue. He has no chest pain or fever. His oxygen saturation is 88% on room air. CT pulmonary angiography shows no pulmonary embolism, but reveals diffuse ground-glass opacities with peripheral sparing. Bronchoalveolar lavage shows lymphocytic predominance with CD4:CD8 ratio of 0.3. Which of the following is the most appropriate next step in management?", "options": ["Discontinue enzalutamide and initiate high-dose corticosteroids", "Initiate empiric broad-spectrum antibiotics for atypical pneumonia", "Add abiraterone to his current regimen and continue enzalutamide", "Perform transbronchial biopsy to rule out lymphangitic carcinomatosis", "Start therapeutic-dose low-molecular-weight heparin for occult pulmonary embolism"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for enzalutamide-induced interstitial pneumonitis, which typically presents with subacute dyspnea, ground-glass opacities on CT, and a lymphocytic BAL with low CD4:CD8 ratio. Immediate discontinuation of the offending agent and initiation of corticosteroids is the standard management. Antibiotics are not indicated without infectious signs, and adding abiraterone would exacerbate the drug-induced lung injury.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: mCRPC on enzalutamide, subacute dyspnea, hypoxemia, CT showing diffuse ground-glass opacities with peripheral sparing, BAL lymphocytic predominance with low CD4:CD8 ratio (0.3), and absence of infection/PE signs. This pattern is highly specific for drug-induced interstitial pneumonitis, making discontinuation and corticosteroids the definitive management. Alternatives are inferior: B lacks infectious signs; C would continue the offending drug; D is unnecessary given diagnostic BAL; E is ruled out by negative CTPA. No contradictions or missing critical details. Medical accuracy is sound, aligning with known enzalutamide pulmonary toxicity and management guidelines. Minimal fix: none needed for logical validity; to enhance clarity, explicitly state 'no signs of infection' in the vignette.\",\n    \"medical_accuracy_score\": 4,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: mCRPC on enzalutamide, subacute dyspnea, hypoxemia, CT showing diffuse ground-glass opacities with peripheral sparing, BAL lymphocytic predominance with low CD4:CD8 ratio (0.3), and absence of infection/PE signs. This pattern is highly specific for drug-induced interstitial pneumonitis, making discontinuation and corticosteroids the definitive management. Alternatives are inferior: B lacks infectious signs; C would continue the offending drug; D is unnecessary given diagnostic BAL; E is ruled out by negative CTPA. No contradictions or missing critical details. Medical accuracy is sound, aligning with known enzalutamide pulmonary toxicity and management guidelines. Minimal fix: none needed for logical validity; to enhance clarity, explicitly state 'no signs of infection' in the vignette.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-002", "question": "A 4-month-old previously healthy infant presents with acute onset of irritability, vomiting, and lethargy. Physical examination reveals a bulging anterior fontanelle, retinal hemorrhages, and no focal neurologic deficits. Non-contrast head CT shows bilateral subdural hematomas of different ages. The infant's coagulation studies and metabolic panel are normal. Which of the following additional findings would most strongly support a diagnosis of glutaric aciduria type 1 rather than non-accidental trauma?", "options": ["Metaphyseal corner fractures on skeletal survey", "Elevated serum ammonia level", "Frontotemporal atrophy with widened Sylvian fissures on MRI", "Subarachnoid hemorrhage extending into the posterior fossa", "Elevated urine organic acids showing 3-hydroxyglutaric aciduria"], "answer": "E", "answer_index": 4, "explanation": "While glutaric aciduria type 1 can mimic non-accidental trauma with acute encephalopathy and subdural hematomas, the definitive diagnosis requires demonstration of elevated urine organic acids, specifically 3-hydroxyglutaric aciduria. Frontotemporal atrophy (option C) is a characteristic neuroimaging finding but is not diagnostic. Metaphyseal fractures strongly suggest abuse, while elevated ammonia suggests a different metabolic disorder.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: V. Verdict: Correct best answer. Key stem clues: 4-month-old with acute encephalopathy, retinal hemorrhages, bilateral subdural hematomas of different ages (classic for non-accidental trauma), normal coagulation/metabolic labs. The question asks for the finding that would MOST STRONGLY SUPPORT glutaric aciduria type 1 over abuse. The best answer is E (elevated urine organic acids showing 3-hydroxyglutaric aciduria) as this is the definitive biochemical diagnostic finding for glutaric aciduria type 1. Option C (frontotemporal atrophy) is a characteristic but non-diagnostic imaging finding. Options A (metaphyseal fractures) strongly suggests abuse. Option B (elevated ammonia) suggests other metabolic disorders. Option D (posterior fossa hemorrhage) is non-specific. Medical accuracy: 4/5 - clinically accurate. Minimal fix: None needed; item is valid and well-constructed.\",\n    \"medical_accuracy_score\": 4,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: 4-month-old with acute encephalopathy, retinal hemorrhages, bilateral subdural hematomas of different ages (classic for non-accidental trauma), normal coagulation/metabolic labs. The question asks for the finding that would MOST STRONGLY SUPPORT glutaric aciduria type 1 over abuse. The best answer is E (elevated urine organic acids showing 3-hydroxyglutaric aciduria) as this is the definitive biochemical diagnostic finding for glutaric aciduria type 1. Option C (frontotemporal atrophy) is a characteristic but non-diagnostic imaging finding. Options A (metaphyseal fractures) strongly suggests abuse. Option B (elevated ammonia) suggests other metabolic disorders. Option D (posterior fossa hemorrhage) is non-specific. Medical accuracy: 4/5 - clinically accurate. Minimal fix: None needed; item is valid and well-constructed.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-003", "question": "A 55-year-old woman with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who failed CAR T-cell therapy 3 months ago presents with new-onset confusion and myoclonus. MRI brain shows symmetric diffusion restriction in the bilateral thalami, basal ganglia, and cerebral cortex. EEG demonstrates periodic sharp wave complexes. CSF shows 12 white cells/mm³ (90% lymphocytes), normal glucose, and elevated protein at 80 mg/dL. Which of the following is the most likely causative agent?", "options": ["Tafasitamab", "Polatuzumab vedotin", "Tisagenlecleucel", "Blinatumomab", "Brentuximab vedotin"], "answer": "C", "answer_index": 2, "explanation": "This presentation is classic for CAR T-cell therapy-related immune effector cell-associated neurotoxicity syndrome (ICANS), which can occur weeks to months after treatment. The MRI pattern of symmetric deep gray matter and cortical involvement with corresponding EEG findings is characteristic. Tisagenlecleucel is a CD19-directed CAR T-cell therapy used in DLBCL. The other agents are monoclonal antibodies or antibody-drug conjugates not typically associated with this specific delayed neurotoxicity pattern.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: relapsed/refractory DLBCL, failed CAR T-cell therapy 3 months ago, new neuropsychiatric symptoms, MRI with symmetric diffusion restriction in deep gray matter and cortex, EEG with periodic sharp wave complexes, CSF with lymphocytic pleocytosis and elevated protein. Main logical issue: The vignette explicitly states CAR T-cell therapy failed 3 months ago, making a new complication from that same therapy (tisagenlecleucel) improbable; the presentation is more characteristic of a late complication like progressive multifocal leukoencephalopathy (PML) associated with immunosuppression, but PML is not among the options. No option is clearly defensible as the 'most likely causative agent' given the failure of CAR T and the delayed timeline. Main medical accuracy issue: Attributing this delayed neurotoxicity to a failed CAR T therapy contradicts typical ICANS onset (usually within days to weeks, not months post-treatment) and the clinical context of treatment failure. Minimal fix: Change the vignette to specify the patient is currently responding to CAR T therapy or recently received it, or replace the options to include PML-associated agents like natalizumab if focusing on late neurotoxicity.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"N\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: relapsed/refractory DLBCL, failed CAR T-cell therapy 3 months ago, new neuropsychiatric symptoms, MRI with symmetric diffusion restriction in deep gray matter and cortex, EEG with periodic sharp wave complexes, CSF with lymphocytic pleocytosis and elevated protein. Main logical issue: The vignette explicitly states CAR T-cell therapy failed 3 months ago, making a new complication from that same therapy (tisagenlecleucel) improbable; the presentation is more characteristic of a late complication like progressive multifocal leukoencephalopathy (PML) associated with immunosuppression, but PML is not among the options. No option is clearly defensible as the 'most likely causative agent' given the failure of CAR T and the delayed timeline. Main medical accuracy issue: Attributing this delayed neurotoxicity to a failed CAR T therapy contradicts typical ICANS onset (usually within days to weeks, not months post-treatment) and the clinical context of treatment failure. Minimal fix: Change the vignette to specify the patient is currently responding to CAR T therapy or recently received it, or replace the options to include PML-associated agents like natalizumab if focusing on late neurotoxicity.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-004", "question": "A critically ill patient with septic shock on norepinephrine (0.3 mcg/kg/min) and vasopressin (0.03 units/min) develops refractory hypotension. Transthoracic echocardiogram shows a hyperdynamic left ventricle with collapsing mitral inflow pattern. Which of the following interventions is most likely to improve hemodynamics without increasing myocardial oxygen demand?", "options": ["Initiate dobutamine infusion at 5 mcg/kg/min", "Add phenylephrine infusion to target MAP >65 mmHg", "Administer 500 mL 5% albumin bolus", "Start angiotensin II infusion at 20 ng/kg/min", "Increase norepinephrine to 0.5 mcg/kg/min"], "answer": "D", "answer_index": 3, "explanation": "The echocardiographic findings suggest distributive shock with relative hypovolemia. Angiotensin II acts via AT1 receptors to cause vasoconstriction without significant inotropic effects, making it ideal for this scenario without increasing myocardial oxygen demand. Dobutamine increases myocardial demand, phenylephrine causes pure alpha-agonism with potential reflex bradycardia, fluid bolus may be insufficient in vasoplegic shock, and increasing norepinephrine adds beta-1 effects that increase oxygen consumption.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - a unique best answer exists but key D is not it. Key stem clues: septic shock on dual vasopressors, refractory hypotension, hyperdynamic LV with collapsing mitral inflow (suggests distributive shock with possible relative hypovolemia). Main logical issue: Key D (angiotensin II) is not the most appropriate choice; option C (albumin bolus) is the best answer given the echocardiographic finding of collapsing mitral inflow pattern indicating preload responsiveness in distributive shock. Main medical accuracy issue: Angiotensin II is not first-line for this scenario and has limited evidence in septic shock; fluid resuscitation remains primary for preload-responsive distributive shock. Minimal fix: Change key from D to C, or modify stem to specify 'after adequate fluid resuscitation' to justify vasopressor escalation.\",\n    \"medical_accuracy_score\": 3,\n    \"logical_validity\": false,\n    \"logical_false_reason\": \"K\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - a unique best answer exists but key D is not it. Key stem clues: septic shock on dual vasopressors, refractory hypotension, hyperdynamic LV with collapsing mitral inflow (suggests distributive shock with possible relative hypovolemia). Main logical issue: Key D (angiotensin II) is not the most appropriate choice; option C (albumin bolus) is the best answer given the echocardiographic finding of collapsing mitral inflow pattern indicating preload responsiveness in distributive shock. Main medical accuracy issue: Angiotensin II is not first-line for this scenario and has limited evidence in septic shock; fluid resuscitation remains primary for preload-responsive distributive shock. Minimal fix: Change key from D to C, or modify stem to specify 'after adequate fluid resuscitation' to justify vasopressor escalation.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-005", "question": "A 7-year-old boy presents with acute cerebellar ataxia following varicella infection 2 weeks prior. MRI shows T2 hyperintensity restricted to the cerebellar hemispheres. CSF demonstrates 15 lymphocytes/mm³, normal glucose, and elevated IgG index. Which of the following autoantibodies is most specific for this condition?", "options": ["Anti-GAD65", "Anti-Hu", "Anti-Yo", "Anti-Tr/DNER", "Anti-mGluR1"], "answer": "D", "answer_index": 3, "explanation": "Post-varicella acute cerebellar ataxia is associated with anti-Tr/DNER (delta/notch-like epidermal growth factor-related receptor) antibodies in a significant proportion of cases. This antibody is highly specific for paraneoplastic cerebellar degeneration in Hodgkin lymphoma but also occurs in post-infectious contexts. Anti-Yo and anti-Hu are associated with gynecological/breast cancers and small cell lung cancer respectively. Anti-mGluR1 is seen in Hodgkin-related ataxia, while anti-GAD65 is associated with stiff-person syndrome.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: pediatric patient, acute cerebellar ataxia following varicella infection, MRI showing cerebellar-restricted T2 hyperintensity, lymphocytic pleocytosis with elevated IgG index. These findings strongly support post-infectious cerebellitis. Anti-Tr/DNER antibodies are well-documented in post-varicella cerebellar ataxia and represent the most specific association among the options. Main logical issue: None - the vignette provides sufficient clinical and laboratory details to uniquely identify anti-Tr/DNER. Main medical accuracy issue: Minor - while anti-Tr/DNER is indeed associated with post-varicella cerebellar ataxia, the explanation's statement about Hodgkin lymphoma association is correct but could be clarified that it's more commonly paraneoplastic. Minimal fix: None needed for logical validity; could add 'most specific' to stem to emphasize discrimination.\",\n    \"medical_accuracy_score\": 4,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: pediatric patient, acute cerebellar ataxia following varicella infection, MRI showing cerebellar-restricted T2 hyperintensity, lymphocytic pleocytosis with elevated IgG index. These findings strongly support post-infectious cerebellitis. Anti-Tr/DNER antibodies are well-documented in post-varicella cerebellar ataxia and represent the most specific association among the options. Main logical issue: None - the vignette provides sufficient clinical and laboratory details to uniquely identify anti-Tr/DNER. Main medical accuracy issue: Minor - while anti-Tr/DNER is indeed associated with post-varicella cerebellar ataxia, the explanation's statement about Hodgkin lymphoma association is correct but could be clarified that it's more commonly paraneoplastic. Minimal fix: None needed for logical validity; could add 'most specific' to stem to emphasize discrimination.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-006", "question": "A 42-year-old woman with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) achieves complete morphological remission after induction chemotherapy. Minimal residual disease (MRD) testing by flow cytometry shows 0.01% blasts. Which of the following factors would most strongly indicate proceeding to allogeneic hematopoietic stem cell transplantation in first complete remission rather than continuing with chemotherapy plus a tyrosine kinase inhibitor?", "options": ["Presence of IKZF1 deletion", "Age >40 years", "MRD positivity after consolidation therapy", "White blood cell count >30,000/μL at diagnosis", "Presence of additional cytogenetic abnormalities besides t(9;22)"], "answer": "C", "answer_index": 2, "explanation": "In Ph+ ALL, MRD positivity after consolidation therapy is the strongest predictor of poor outcome with chemotherapy/TKI alone and is a clear indication for allogeneic transplantation in first remission. While age >40, high WBC, IKZF1 deletion, and additional abnormalities are adverse prognostic factors, contemporary TKI-based regimens can overcome many of these. Persistent MRD after intensive therapy indicates resistant disease requiring transplant for cure.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Ph+ ALL in morphological remission with 0.01% MRD after induction; question asks which factor would MOST strongly indicate proceeding to allogeneic transplant in first CR rather than continuing chemo+TKI. The stem properly sets up the clinical scenario of post-induction decision-making. Main logical issue: None - item is logically valid with clear discrimination. Main medical accuracy issue: None - consistent with current NCCN/ELN guidelines where MRD positivity after consolidation is the strongest transplant indication in Ph+ ALL. Minimal fix: None needed; item is already unambiguous and accurate. Option C (MRD positivity after consolidation) is uniquely defensible as the strongest evidence-based transplant indication, while other factors (age, WBC, genetics) are less definitive in the TKI era.\",\n    \"medical_accuracy_score\": 5,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Ph+ ALL in morphological remission with 0.01% MRD after induction; question asks which factor would MOST strongly indicate proceeding to allogeneic transplant in first CR rather than continuing chemo+TKI. The stem properly sets up the clinical scenario of post-induction decision-making. Main logical issue: None - item is logically valid with clear discrimination. Main medical accuracy issue: None - consistent with current NCCN/ELN guidelines where MRD positivity after consolidation is the strongest transplant indication in Ph+ ALL. Minimal fix: None needed; item is already unambiguous and accurate. Option C (MRD positivity after consolidation) is uniquely defensible as the strongest evidence-based transplant indication, while other factors (age, WBC, genetics) are less definitive in the TKI era.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-007", "question": "A 65-year-old man with atrial fibrillation on apixaban presents with acute onset of aphasia and right hemiparesis. CT head shows a 3 cm left MCA territory infarct with no hemorrhage. Last apixaban dose was 4 hours ago. NIH Stroke Scale is 18. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator immediately", "Give 4-factor prothrombin complex concentrate followed by tPA", "Perform emergent mechanical thrombectomy without thrombolysis", "Administer andexanet alfa followed by mechanical thrombectomy", "Give idarucizumab empirically followed by mechanical thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "For large vessel occlusion strokes in patients on direct oral anticoagulants (DOACs) with recent dosing, mechanical thrombectomy without thrombolysis is recommended due to the increased risk of hemorrhagic transformation with tPA. Andexanet alfa is a reversal agent for factor Xa inhibitors but is not routinely recommended prior to thrombectomy unless there is life-threatening bleeding. Idarucizumab is for dabigatran reversal. PCC before tPA still carries bleeding risk and delays intervention.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - mechanical thrombectomy is appropriate but NOT without considering thrombolysis. Key stem clues: acute ischemic stroke with LVO (3cm left MCA infarct), NIHSS 18, on apixaban (last dose 4h ago), no hemorrhage. Main logical issue: Option C suggests thrombectomy WITHOUT thrombolysis, but current guidelines (AHA/ASA 2023) recommend IV alteplase for eligible patients on DOACs if last dose >48h OR if specific lab criteria are met; with last dose 4h ago, alteplase is contraindicated, making option A incorrect. However, option B (PCC followed by tPA) is also incorrect due to bleeding risk. The unique best answer is mechanical thrombectomy, but the phrasing 'without thrombolysis' in C is unnecessary and potentially misleading; a better option would simply state 'Perform emergent mechanical thrombectomy.' Medical accuracy: Mostly accurate but lacks nuance about DOAC-specific lab testing for thrombolysis eligibility. Minimal fix: Change option C to 'Perform emergent mechanical thrombectomy' (remove 'without thrombolysis') to match guidelines.\",\n    \"medical_accuracy_score\": 4,\n    \"logical_validity\": false,\n    \"logical_false_reason\": \"K\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - mechanical thrombectomy is appropriate but NOT without considering thrombolysis. Key stem clues: acute ischemic stroke with LVO (3cm left MCA infarct), NIHSS 18, on apixaban (last dose 4h ago), no hemorrhage. Main logical issue: Option C suggests thrombectomy WITHOUT thrombolysis, but current guidelines (AHA/ASA 2023) recommend IV alteplase for eligible patients on DOACs if last dose >48h OR if specific lab criteria are met; with last dose 4h ago, alteplase is contraindicated, making option A incorrect. However, option B (PCC followed by tPA) is also incorrect due to bleeding risk. The unique best answer is mechanical thrombectomy, but the phrasing 'without thrombolysis' in C is unnecessary and potentially misleading; a better option would simply state 'Perform emergent mechanical thrombectomy.' Medical accuracy: Mostly accurate but lacks nuance about DOAC-specific lab testing for thrombolysis eligibility. Minimal fix: Change option C to 'Perform emergent mechanical thrombectomy' (remove 'without thrombolysis') to match guidelines.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-008", "question": "A 3-year-old child with DiGeorge syndrome (22q11.2 deletion) presents with hypocalcemic seizures. Correction of calcium with intravenous calcium gluconate and calcitriol is initiated. Which of the following immunologic parameters, if present, would be an absolute contraindication to live viral vaccination?", "options": ["CD4+ T cell count <500 cells/μL", "Absent thymic shadow on chest radiograph", "Low but detectable T cell receptor excision circles (TRECs)", "Severely reduced proliferative response to phytohemagglutinin", "Complete absence of CD3+ T cells by flow cytometry"], "answer": "E", "answer_index": 4, "explanation": "Complete absence of CD3+ T cells indicates severe combined immunodeficiency (SCID) phenotype within DiGeorge spectrum, which is an absolute contraindication to live vaccines due to risk of disseminated infection. Reduced proliferative responses (option D) indicate functional impairment but not complete absence. Low TRECs suggest poor thymic output but not necessarily SCID. CD4 count and thymic shadow are not definitive contraindications alone.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: V. Verdict: Correct best answer. Key stem clues: DiGeorge syndrome with hypocalcemic seizures establishes thymic dysfunction; the question specifically asks for an immunologic parameter that would be an absolute contraindication to live viral vaccination. Complete absence of CD3+ T cells (option E) definitively indicates severe T-cell deficiency/SCID, which is a clear contraindication per standard guidelines. The other options represent varying degrees of impairment but not absolute contraindications: CD4 count <500 (A) is not absolute; absent thymic shadow (B) is anatomical; low TRECs (C) indicates poor output; reduced proliferative response (D) indicates functional impairment. No logical issues; the item correctly discriminates based on severity of immunodeficiency. Medical accuracy is sound. Minimal fix: None needed; item is clear and accurate.\",\n    \"medical_accuracy_score\": 5,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: DiGeorge syndrome with hypocalcemic seizures establishes thymic dysfunction; the question specifically asks for an immunologic parameter that would be an absolute contraindication to live viral vaccination. Complete absence of CD3+ T cells (option E) definitively indicates severe T-cell deficiency/SCID, which is a clear contraindication per standard guidelines. The other options represent varying degrees of impairment but not absolute contraindications: CD4 count <500 (A) is not absolute; absent thymic shadow (B) is anatomical; low TRECs (C) indicates poor output; reduced proliferative response (D) indicates functional impairment. No logical issues; the item correctly discriminates based on severity of immunodeficiency. Medical accuracy is sound. Minimal fix: None needed; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-009", "question": "A patient with glioblastoma on temozolomide and dexamethasone develops progressive headache, visual changes, and diabetes insipidus. MRI shows thickening and enhancement of the pituitary stalk with loss of the posterior pituitary bright spot. CSF cytology is negative. Which of the following findings would most strongly support a diagnosis of lymphocytic hypophysitis over pituitary metastasis?", "options": ["Presence of anti-pituitary antibodies", "Elevated CSF beta-2 transferrin", "Simultaneous involvement of the pineal gland", "Rapid improvement with high-dose corticosteroids", "Association with other autoimmune endocrine deficiencies"], "answer": "E", "answer_index": 4, "explanation": "Lymphocytic hypophysitis frequently presents with other autoimmune endocrine deficiencies (thyroiditis, adrenalitis, diabetes mellitus type 1), while pituitary metastases typically occur in isolation. Anti-pituitary antibodies have poor sensitivity/specificity. CSF beta-2 transferrin indicates CSF leak. Pineal involvement suggests germinoma. Steroid responsiveness occurs in both conditions but is more dramatic in hypophysitis; however, association with other autoimmune conditions is more specific.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Glioblastoma patient on temozolomide/dexamethasone with pituitary stalk thickening/enhancement, posterior pituitary bright spot loss, negative CSF cytology, and diabetes insipidus. The question asks what finding most strongly distinguishes lymphocytic hypophysitis from pituitary metastasis. Main logical issue: None - the item is logically sound. Main medical accuracy issue: None - the clinical reasoning aligns with standard endocrine/oncology knowledge. Lymphocytic hypophysitis is indeed strongly associated with other autoimmune endocrine deficiencies, while pituitary metastases typically occur in isolation. Minimal fix: None needed; the item is already unambiguous and accurate.\",\n    \"medical_accuracy_score\": 4,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Glioblastoma patient on temozolomide/dexamethasone with pituitary stalk thickening/enhancement, posterior pituitary bright spot loss, negative CSF cytology, and diabetes insipidus. The question asks what finding most strongly distinguishes lymphocytic hypophysitis from pituitary metastasis. Main logical issue: None - the item is logically sound. Main medical accuracy issue: None - the clinical reasoning aligns with standard endocrine/oncology knowledge. Lymphocytic hypophysitis is indeed strongly associated with other autoimmune endocrine deficiencies, while pituitary metastases typically occur in isolation. Minimal fix: None needed; the item is already unambiguous and accurate.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-010", "question": "A neonate born at 32 weeks gestation develops necrotizing enterocolitis (NEC) on day 10 of life. During laparotomy, approximately 40% of the small bowel appears necrotic. Which of the following intraoperative findings would mandate creation of a high jejunostomy rather than primary anastomosis?", "options": ["Involvement of the ileocecal valve", "Necrosis extending to within 5 cm of the ligament of Treitz", "Presence of pneumatosis intestinalis in the remaining bowel", "Concurrent isolated perforation of the gastric fundus", "Development of abdominal compartment syndrome during surgery"], "answer": "B", "answer_index": 1, "explanation": "Necrosis extending to within 5 cm of the ligament of Treitz indicates near-total small bowel loss, requiring high jejunostomy to preserve the maximal possible length of viable bowel for future adaptation and prevent anastomotic leakage in compromised tissue. Ileocecal valve involvement is important for absorption but doesn't dictate anastomosis vs ostomy. Pneumatosis may be present in non-necrotic bowel. Gastric perforation is managed separately. Abdominal compartment syndrome may require temporary closure but not necessarily jejunostomy.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: NEC in 32-week preterm neonate, day 10 of life, 40% small bowel necrotic at laparotomy. The question asks which intraoperative finding specifically mandates high jejunostomy over primary anastomosis. Option B (necrosis within 5 cm of ligament of Treitz) correctly indicates proximal jejunal involvement where insufficient viable bowel remains for safe anastomosis, requiring ostomy. Alternatives are less specific: A (ileocecal valve) affects absorption but not anastomosis decision; C (pneumatosis) indicates disease but not viability; D (gastric perforation) is separate management; E (compartment syndrome) requires temporary closure, not specific ostomy creation. Medical accuracy is sound: proximal necrosis is a recognized indication for jejunostomy in NEC to preserve length and avoid anastomotic failure in compromised tissue. Minimal fix: None needed; item is clear and valid.\",\n    \"medical_accuracy_score\": 4,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: NEC in 32-week preterm neonate, day 10 of life, 40% small bowel necrotic at laparotomy. The question asks which intraoperative finding specifically mandates high jejunostomy over primary anastomosis. Option B (necrosis within 5 cm of ligament of Treitz) correctly indicates proximal jejunal involvement where insufficient viable bowel remains for safe anastomosis, requiring ostomy. Alternatives are less specific: A (ileocecal valve) affects absorption but not anastomosis decision; C (pneumatosis) indicates disease but not viability; D (gastric perforation) is separate management; E (compartment syndrome) requires temporary closure, not specific ostomy creation. Medical accuracy is sound: proximal necrosis is a recognized indication for jejunostomy in NEC to preserve length and avoid anastomotic failure in compromised tissue. Minimal fix: None needed; item is clear and valid.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]